These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1616638)

  • 1. Mother-to-infant transmission of HIV and hepatitis C infections in children born to HIV-seropositive mothers.
    Perez Alvarez L; Gurbindo MD; Hernandez-Sampelayo T; Casada C; Leon P; Garcia Saiz A; De Andres R; Najera R
    AIDS; 1992 Apr; 6(4):427-8. PubMed ID: 1616638
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.
    Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F
    Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The risk of vertical HCV transmission in children born to HIV infected mothers].
    Dobosz S
    Przegl Epidemiol; 2007; 61(2):349-56. PubMed ID: 17956053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. Study Group for Vertical Transmission.
    Mazza C; Ravaggi A; Rodella A; Padula D; Duse M; Lomini M; Puoti M; Rossini A; Cariani E
    J Med Virol; 1998 Jan; 54(1):12-9. PubMed ID: 9443104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric Hepatitis C Virus Network.
    European Paediatric Hepatitis C Virus Network.
    BJOG; 2001 Apr; 108(4):371-7. PubMed ID: 11305543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurological complications of HIV-1 infection in an infant born to a seropositive mother].
    Tardieu M
    Rev Neurol (Paris); 1998 Dec; 154(12):850-5. PubMed ID: 9932306
    [No Abstract]   [Full Text] [Related]  

  • 7. Mother to child transmission of hepatitis C virus: rate of infection and risk factors.
    Syriopoulou V; Nikolopoulou G; Daikos GL; Theodoridou M; Pavlopoulou I; Nicolaidou P; Manolaki N
    Scand J Infect Dis; 2005; 37(5):350-3. PubMed ID: 16051571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic HIV-infection in infants according to serostatus of mothers during pregnancy.
    Olayinka BA; Obi CL
    East Afr Med J; 1999 Oct; 76(10):566-70. PubMed ID: 10734507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?
    Mariné-Barjoan E; Berrébi A; Giordanengo V; Favre SF; Haas H; Moreigne M; Izopet J; Tricoire J; Tran A; Pradier C; Bongain A
    AIDS; 2007 Aug; 21(13):1811-5. PubMed ID: 17690581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetric management of hepatitis C-positive mothers: analysis of vertical transmission in 559 mother-infant pairs.
    McMenamin MB; Jackson AD; Lambert J; Hall W; Butler K; Coulter-Smith S; McAuliffe FM
    Am J Obstet Gynecol; 2008 Sep; 199(3):315.e1-5. PubMed ID: 18771997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing.
    Roudot-Thoraval F; Pawlotsky JM; Thiers V; Deforges L; Girollet PP; Guillot F; Huraux C; Aumont P; Brechot C; Dhumeaux D
    Hepatology; 1993 May; 17(5):772-7. PubMed ID: 7684017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau.
    Andreasson PA; Dias F; Nauclér A; Andersson S; Biberfeld G
    AIDS; 1993 Jul; 7(7):989-93. PubMed ID: 8357558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors.
    Dal Molin G; D'Agaro P; Ansaldi F; Ciana G; Fertz C; Alberico S; Campello C
    J Med Virol; 2002 Jun; 67(2):137-42. PubMed ID: 11992574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High efficiency of vertical transmission of hepatitis C virus among babies born to human immunodeficiency virus-negative women.
    Maccabruni A; Bossi G; Caselli D; Cividini A; Silini E; Mondelli MU
    Pediatr Infect Dis J; 1995 Oct; 14(10):921-2. PubMed ID: 8584333
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs.
    Resti M; Azzari C; Galli L; Zuin G; Giacchino R; Bortolotti F; Marcellini M; Moriondo M; de Martino M; Vierucci A;
    J Infect Dis; 2002 Mar; 185(5):567-72. PubMed ID: 11865412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of mother-to-infant HIV transmission in tribal women from India.
    Kumar RM; Uduman SA; Khurranna AK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):238-42. PubMed ID: 7788422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV vertical transmission in infants born to HIV-HCV seropositive mothers.
    Maccabruni A; Caselli D; Degioanni M
    Ann N Y Acad Sci; 1993 Oct; 693():284-5. PubMed ID: 8267280
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV positive mothers and their children].
    Salo E; Savonius H; Leinikki P; Paavonen J; Suni J; Lähdevirta J
    Duodecim; 1998; 114(5):417-22. PubMed ID: 11466932
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-1 env-specific cellular cytotoxicity in HIV-1-seropositive mothers and their infants.
    Skowron G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S79-82. PubMed ID: 7865338
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
    Pol S
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B264-73. PubMed ID: 12180300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.